Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.35B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.1B |
| 3 |
Apple
AAPL
|
+$556M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$488M |
| 5 |
Coca-Cola
KO
|
+$464M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.15B |
| 3 |
Microsoft
MSFT
|
+$777M |
| 4 |
McDonald's
MCD
|
+$585M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$549M |
Sector Composition
| 1 | Technology | 16.54% |
| 2 | Healthcare | 16.17% |
| 3 | Consumer Discretionary | 11.83% |
| 4 | Financials | 10.91% |
| 5 | Industrials | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4776
Cellectar Biosciences
CLRB
$16.4M
| $126K | ﹤0.01% |
1,674
-2,249
| -57% | -$169K |
|
4777
IceCure Medical
ICCM
$70M
| $125K | ﹤0.01% |
+169,512
| New | +$125K |
|
4778
Village Farms International
VFF
$296M
| $125K | ﹤0.01% |
122,928
-138,559
| -53% | -$141K |
|
|
GDO
4779
Western Asset Global Corporate Defined Opportunity Fund
GDO
$90.9M
| $125K | ﹤0.01% |
+10,263
| New | +$125K |
|
4780
FreightCar America
RAIL
$165M
| $124K | ﹤0.01% |
35,573
-6,822
| -16% | -$23.8K |
|
4781
The Oncology Institute
TOI
$281M
| $124K | ﹤0.01% |
269,704
+239,558
| +795% | +$110K |
|
4782
Cardiff Oncology
CRDF
$133M
| $124K | ﹤0.01% |
+55,796
| New | +$124K |
|
|
PHLT
4783
Performant Healthcare, Inc. Common Stock
PHLT
$611M
| $124K | ﹤0.01% |
42,629
-27,238
| -39% | -$79K |
|
4784
Wave Life Sciences
WVE
$1.09B
| $123K | ﹤0.01% |
24,716
-59,913
| -71% | -$299K |
|
|
MCHB
4785
Mechanics Bancorp Class A Common Stock
MCHB
$2.89B
| $123K | ﹤0.01% |
10,785
+3,253
| +43% | +$37.1K |
|
4786
Global X SuperDividend US ETF
DIV
$644M
| $122K | ﹤0.01% |
7,086
+2,418
| +52% | +$41.7K |
|
|
HEPS
4787
D-Market Electronic Services & Trading
HEPS
$932M
| $122K | ﹤0.01% |
55,206
-50,894
| -48% | -$112K |
|
4788
ON24
ONTF
$233M
| $122K | ﹤0.01% |
20,260
+5,533
| +38% | +$33.3K |
|
|
DSL
4789
DoubleLine Income Solutions Fund
DSL
$1.43B
| $121K | ﹤0.01% |
9,686
-107
| -1% | -$1.34K |
|
|
BCOV
4790
DELISTED
Brightcove, Inc.
BCOV
| $121K | ﹤0.01% |
50,935
-15,584
| -23% | -$36.9K |
|
4791
Coffee Holding Co
JVA
$27.3M
| $121K | ﹤0.01% |
51,509
+21,411
| +71% | +$50.1K |
|
4792
iShares Convertible Bond ETF
ICVT
$2.9B
| $120K | ﹤0.01% |
+1,529
| New | +$120K |
|
4793
Prelude Therapeutics
PRLD
$65.7M
| $120K | ﹤0.01% |
31,388
+1,593
| +5% | +$6.07K |
|
4794
Global X SuperIncome Preferred ETF
SPFF
$138M
| $120K | ﹤0.01% |
12,979
-47,885
| -79% | -$441K |
|
4795
LAVA Therapeutics
LVTX
$39.7M
| $119K | ﹤0.01% |
+66,237
| New | +$119K |
|
4796
Heritage Insurance Holdings
HRTG
$759M
| $119K | ﹤0.01% |
16,787
+11,587
| +223% | +$82K |
|
4797
Primis Financial Corp
FRST
$264M
| $119K | ﹤0.01% |
+11,333
| New | +$119K |
|
4798
Escalade
ESCA
$170M
| $118K | ﹤0.01% |
+8,584
| New | +$118K |
|
|
HAYN
4799
DELISTED
Haynes International, Inc.
HAYN
| $118K | ﹤0.01% |
2,016
-1,870
| -48% | -$110K |
|
4800
Arq
ARQ
$306M
| $118K | ﹤0.01% |
19,433
-22,595
| -54% | -$137K |
|